Quantifying the incidence and burden of postinfectious enteric sequelae

Military Medicine

Volumn 178, Issue 4, 2013, Pages 452-469

  Porter, Chad K ^a   Thura, Nadia ^a   Riddle, Mark S ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; DIARRHEA; HUMAN; INCIDENCE; INFECTION; MORBIDITY; SOLDIER; TRENDS; UNITED STATES; REVIEW;

DIARRHEA; HUMANS; INCIDENCE; INFECTION; MILITARY PERSONNEL; MORBIDITY; UNITED STATES;

EID: 84875781765     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-12-00510     Document Type: Article

References (92)

1. DeFraites RF, Richards EE: Assessing potentially hazardous environmental exposures among military populations: 2010 symposium workshop summary and conclusions. Mil Med 2011; 176(7 Suppl): 17-21.
2. Helmick K, Baugh L, Lattimore T, Goldman S: Traumatic brain injury: next steps, research needed, and priority focus areas. Mil Med 2012; 177: 86-92.
3. Hermann BA, Shiner B, Friedman MJ: Epidemiology and prevention of combat-related post-traumatic stress in OEF/OIF/OND service members. Mil Med 2012; 177(Suppl 8): 1-6.
4. Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM: Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 2007; 37: 48-55.
5. Parry SD, Stansfield R, Jelley D, et al: Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. AmJ Gastroenterol 2003; 98: 1970-5.
6. Porter CK, Gormley R, Tribble DR, Cash BD, Riddle MS: The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am J Gastroenterol; 106: 130-8.
7. Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O'Brien SJ: Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis 2006; 194: 95-7.
8. Garcia Rodriguez LA, Ruigomez A, Panes J: Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 1588-94.
9. Jess T, Simonsen J, Nielsen NM, et al: Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 2011; 60: 318-24.
10. Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS: Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008; 135: 781-6.
11. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H: Increased short-and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 2009; 137: 495-501.
12. Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J: Short-and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 2008; 14: 143-8.
13. Riddle MS, Sanders JW, Putnam SD, Tribble DR: Incidence, etiology, and impact of diarrhea among long-term travelers (U.S. military and similar populations): a systematic review. Am J Trop Med Hyg 2006; 74: 891-900.
14. World Health Organization: National Burden of Disease Supplementary Files, Health statistics and health information systems. Available at http://www.who.int/healthinfo/global_burden_disease/tools_national/en/ index.html; accessed June 2011.
15. Institute of Medicine (IOM): Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence, pp 21-6. Washington, DC, The National Academies Press, 2008. Available at http://www.nap.edu/catalog/ 11955.html; accessed November 12, 2012.
16. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM: Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010; 59: 605-11.
17. Bernsen RA, de Jager AE, Schmitz PI, van der Meche FG: Long-term impact on work and private life after Guillain-Barre syndrome. J Neurol Sci 2002; 201: 13-7.
18. Hannu T: Reactive arthritis. Best Pract Res Clin Rheumatol 2011; 25: 347-57.
19. Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery. Report 978-0-8330-4454-9. Santa Monica, CA, The RAND Corporation, 2008. Available at www.rand.org/pubs/monographs/2008/RAND_MG720.pdf; accessed December 8, 2012.
20. Institute of Medicine: Long-term Consequences of Traumatic Brain Injury. In Gulf War and Health, Vol 7. Washington, DC, The National Academic Press, 2008. Available at http://www.nap.edu/catalog/12436. html; accessed November 12, 2012.
21. Gaylord KM, Cooper DB, Mercado JM, Kennedy JE, Yoder LH, Holcomb JB: Incidence of posttraumatic stress disorder and mild traumatic brain injury in burned service members: preliminary report. J Trauma 2008; 64: S200-5; discussion S5-6.
22. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA: Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 2008; 358: 453-63.
23. Sayer NA, Chiros CE, Sigford B, et al: Characteristics and rehabilitation outcomes among patients with blast and other injuries sustained during the Global War on Terror. Arch Phys Med Rehabil 2008; 89: 163-70.
24. Schneiderman AI, Braver ER, Kang HK: Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. Am J Epidemiol 2008; 167: 1446-52.
25. Terrio H, Brenner LA, Ivins BJ, et al: Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team. J Head Trauma Rehabil 2009; 24: 14-23.
26. McCarthy N, Andersson Y, Jormanainen V, Gustavsson O, Giesecke J: The risk of Guillain-Barre syndrome following infection with Campylobacter jejuni. Epidemiol Infect 1999; 122: 15-7.
27. McCarthy N, Giesecke J: Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni. Am J Epidemiol 2001; 153: 610-4.
28. Nelson L, Gormley R, Riddle MS, Tribble DR, Porter CK: The epidemiology of Guillain-Barre Syndrome in U.S. military personnel: a casecontrol study. BMC Res Notes 2009; 2: 171.
29. Inman RD, Johnston ME, Hodge M, Falk J, Helewa A: Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 1988; 31: 1377-83.
30. Thomson GT, Chiu B, De Rubeis D, Falk J, Inman RD: Immunoepidemiology of post-Salmonella reactive arthritis in a cohort of women. Clin Immunol Immunopathol 1992; 64: 227-32.
31. Thomson GT, DeRubeis DA, Hodge MA, Rajanayagam C, Inman RD: Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort. Am J Med 1995; 98: 13-21.
32. Halvorson HA, Schlett CD, Riddle MS: Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 2006; 101: 1894-9; quiz 942.
33. Thabane M, Kottachchi DT, Marshall JK: Systematic review and metaanalysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 535-44.
34. Haagsma JA, van der Zanden B, Tariq L, Van Pelt W, van Duynhoven YT, Havelaar AH: Disease Burden and Costs of Selected Foodborne Pathogens in the Netherlands, 2006. RIVM Report 330331001/2009. National Institute for Public Health and the Environment, 2009. Available at http://www.rivm.nl/bibliotheek/rapporten/330331001.html; accessed November 12, 2012.
35. Haagsma JA, Havelaar AH, Janssen BM, Bonsel GJ: Disability Adjusted Life Years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens. Popul Health Metr 2008; 6: 7.
36. Haagsma JA, van Beeck EF, Polinder S, Hoeymans N, Mulder S, Bonsel GJ: Novel empirical disability weights to assess the burden of non-fatal injury. Inj Prev 2008; 14: 5-10.
37. Haagsma JA, van Beeck EF, Polinder S, Toet H, Panneman M, Bonsel GJ: The effect of comorbidity on health-related quality of life for injury patients in the first year following injury: comparison of three comorbidity adjustment approaches. Popul Health Metr 2011; 9: 10.
38. Hoang HT, Pham TL, Vo TT, Nguyen PK, Doran CM, Hill PS: The costs of traumatic brain injury due to motorcycle accidents in Hanoi, Vietnam. Cost Eff Resour Alloc 2008; 6: 17.
39. Gray GC, Coate BD, Anderson CM, et al: The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med 1996; 335: 1505-13.
40. Sostek MB, Jackson S, Linevsky JK, Schimmel EM, Fincke BG: High prevalence of chronic gastrointestinal symptoms in a National Guard Unit of Persian Gulf veterans. Am J Gastroenterol 1996; 91: 2494-7.
41. Marshall KR, Holland SL, Meyer KS, Martin EM, Wilmore M, Grimes JB: Mild traumatic brain injury screening, diagnosis, and treatment. Mil Med; 177: 67-75.
42. Institute of Medicine: Infectious disease pp 1-8. In: Gulf War and Health, Vol 5. Washington, DC, The National Academic Press, 2006. Available at http://www.nap.edu/catalog/11765.html; accessed November 12, 2012.
43. Department of Veterans Affairs. Presumptions of Service Connection for Persian Gulf Service. Federal Register: Rules and Regulations, 2010; 38 CFR Part 3 (Vol. 75, No. 188): 59968-59972. Available at http:// regulations.justia.com/regulations/fedreg/2010/09/29/2010-24360.html; accessed November 12, 2012.
44. Andersen J, Wade M, Possemato K, Ouimette P: Association between posttraumatic stress disorder and primary care provider-diagnosed disease among Iraq and Afghanistan veterans. Psychosom Med 2010; 72: 498-504.
45. Magruder KM, Frueh BC, Knapp RG, et al: Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. Gen Hosp Psychiatry 2005; 27: 169-79.
46. Porter CK, Gloor K, Cash BD, Riddle MS: Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment. Dig Dis Sci 2011; 56: 3262-9.
47. Drossman DA: Abuse, trauma, and GI illness: is there a link? Am J Gastroenterol 2011; 106: 14-25.
48. Anand S, Hanson K: Disability-adjusted life years: a critical review. J Health Econ 1997; 16: 685-702.
49. Bevan G, Hollinghurst S: Cost per quality-adjusted life year and disabilityadjusted life years: the need for a newparadigm. ExpertRev Pharmacoecon Outcomes Res 2003; 3: 469-77.
50. Pitzurra R, Fried M, Rogler G, et al: Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations. J Travel Med 2011; 18: 250-6.
51. Hanevik K, Dizdar V, Langeland N, Hausken T: Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009; 9: 27.
52. Marshall JK, Thabane M, Borgaonkar MR, James C: Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007; 5: 457-60.
53. Piche T, Vanbiervliet G, Pipau FG, et al: Low risk of irritable bowel syndrome after Clostridium difficile infection. Can J Gastroenterol 2007; 21: 727-31.
54. Ruigomez A, Garcia Rodriguez LA, Panes J: Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007; 5: 465-9.
55. Soyturk M, Akpinar H, Gurler O, et al: Irritable bowel syndrome in persons who acquired trichinellosis. Am J Gastroenterol 2007; 102: 1064-9.
56. Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM: The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci 2006; 51: 1026-32.
57. Kim HS, Kim MS, Ji SW, Park H: The development of irritable bowel syndrome after Shigella infection: 3 year follow-up study. Korean J Gastroenterol 2006; 47: 300-5.
58. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM: Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131: 445-50; quiz 660.
59. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A: Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006; 43: 898-901.
60. Ji S, Park H, Lee D, Song YK, Choi JP, Lee SI: Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 381-6.
61. Mearin F, Perez-Oliveras M, Perello A, et al: Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98-104.
62. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL: Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99: 1774-8.
63. Wang LH, Fang XC, Pan GZ: Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-101.
64. Cumberland P, Sethi D, Roderick PJ, et al: The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode. Epidemiol Infect 2003; 130: 453-60.
65. Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR: Posttraveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 2003; 98: 596-9.
66. Rodriguez LA, Ruigomez A: Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999; 318: 565-6.
67. Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779-82.
68. Gwee KA, Graham JC, McKendrick MW, et al: Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
69. McKendrick MW, Read NW: Irritable bowel syndrome: post Salmonella infection. J Infect 1994; 29: 1-3.
70. Uotila T, Antonen J, Laine J, et al: Reactive arthritis in a population exposed to an extensive waterborne gastroenteritis outbreak after sewage contamination in Pirkanmaa, Finland. Scand J Rheumatol 2011; 40: 358-62.
71. Curry JA, Riddle MS, Gormley RP, Tribble DR, Porter CK: The epidemiology of infectious gastroenteritis related reactive arthritis in U.S. military personnel: a case-control study. BMC Infect Dis 2010; 10: 266.
72. Garg AX, Pope JE, Thiessen-Philbrook H, Clark WF, Ouimet J: Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford) 2008; 47: 200-4.
73. Rohekar S, Tsui FW, Tsui HW, et al: Symptomatic acute reactive arthritis after an outbreak of Salmonella. J Rheumatol 2008; 35: 1599-602.
74. Schiellerup P, Krogfelt KA, Locht H: A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. J Rheumatol 2008; 35: 480-7.
75. Townes JM: Reactive arthritis after enteric infections in the United States: the problem of definition. Clin Infect Dis 2009; 50: 247-54.
76. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M: Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis 2005; 64: 594-8.
77. Rees JR, Pannier MA, McNees A, Shallow S, Angulo FJ, Vugia DJ: Persistent diarrhea, arthritis, and other complications of enteric infections: a pilot survey based on California FoodNet surveillance, 1998-1999. Clin Infect Dis 2004; 38(Suppl 3): S311-7.
78. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M: Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis 2002; 61: 264-6.
79. Hannu T, Mattila L, Rautelin H, et al: Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) 2002; 41: 312-8.
80. Locht H, Molbak K, Krogfelt KA: High frequency of reactive joint symptoms after an outbreak of Salmonella enteritidis. J Rheumatol 2002; 29: 767-71.
81. Dworkin MS, Shoemaker PC, Goldoft MJ, Kobayashi JM: Reactive arthritis and Reiter's syndrome following an outbreak of gastroenteritis caused by Salmonella enteritidis. Clin Infect Dis 2001; 33: 1010-4.
82. McColl GJ, Diviney MB, Holdsworth RF, et al: HLA-B27 expression and reactive arthritis susceptibility in two patient cohorts infected with Salmonella typhimurium. Aust N Z J Med 2000; 30: 28-32.
83. Mattila L, Leirisalo-Repo M, Pelkonen P, Koskimies S, Granfors K, Siitonen A: Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. J Infect 1998; 36: 289-95.
84. Bremell T, Bjelle A, Svedhem A: Rheumatic symptoms following an outbreak of Campylobacter enteritis: a five year follow up. Ann Rheum Dis 1991; 50: 934-8.
85. Lauhio A, Lahdevirta J, Janes R, Kontiainen S, Repo H: Reactive arthritis associated with Shigella sonnei infection. ArthritisRheum1988; 31: 1190-3.
86. Eastmond CJ, Rennie JA, Reid TM: An outbreak of Campylobacter enteritis-a rheumatological follow up survey. J Rheumatol 1983; 10: 107-8.
87. Kosunen TU, Kauranen O, Martio J, et al: Reactive arthritis after Campylobacter jejuni enteritis in patients with HLA-B27. Lancet 1980; 1: 1312-3.
88. Hakansson U, Eitrem R, Low B, Winblad S: HLA-antigen b27 in cases with joint affections in an outbreak of salmonellosis. Scand J Infect Dis 1976; 8: 245-8.
89. Sanderson K, Andrews G: Mental disorders and burden of disease: how was disability estimated and is it valid? Aust N Z J Psychiatry 2001; 35: 668-76.
90. Mathers C, Vos T, Stevenson C: The burden of disease and injury in Australia. Canberra, Australian Institute of Health and Welfare catalog no. PHE 17, 1999. Available at http://www.aihw.gov.au/publication-detail/? id=6442467088; accessed November 12, 2012.
91. Murray CJL, Lopez AD: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020, Annex Table 3. Cambridge, MA, Harvard University Press, 1996.
92. Havelaar AH, de Wit MA, van Koningsveld R, van Kempen E: Health burden in the Netherlands due to infection with thermophilic Campylobacter spp. Epidemiol Infect 2000; 125: 505-22.